Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

<div>Kaplan–Meier curves of (a) metastasis and (b) event-free survival dichotomised based on GR expression above (high) or below (low) the median in the publicly available datasets GSE58812 (<i>N</i> = 107) and GSE31519 (<i>N</i> = 62), respectively. (c) Kaplan–Meier curves of (i) relapse free survival and (ii) overall survival dichotomised based on GR expression above (high) or below (low) the median in the publicly available dataset GSE7390 (<i>N</i> = 64).</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 

Figure 2 | Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 